Multiple Sclerosis

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Register here to gain access to SAGE's 500+ Journals Online

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lazeron, R H.
Right arrow Articles by Polman, C H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lazeron, R H.
Right arrow Articles by Polman, C H
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Multiple Sclerosis, Vol. 11, No. 5, 524-531 (2005)
DOI: 10.1191/1352458505ms1201oa

Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis

R HC Lazeron

MS Center, Vrije Universiteit Medical Center, Amsterdam, the Netherlands, Department of Radiology, Vrije Universiteit Medical Center, Amsterdam, the Netherlands, Department of Neurology, Vrije Universiteit Medical Center, Amsterdam, the Netherlands, rhc.lazeron{at}vumc.nl

J B Boringa

MS Center, Vrije Universiteit Medical Center, Amsterdam, the Netherlands, Department of Neurology, Vrije Universiteit Medical Center, Amsterdam, the Netherlands

M Schouten

MS Center, Vrije Universiteit Medical Center, Amsterdam, the Netherlands, Department of Neurology, Vrije Universiteit Medical Center, Amsterdam, the Netherlands

B MJ Uitdehaag

MS Center, Vrije Universiteit Medical Center, Amsterdam, the Netherlands, Department of Neurology, Vrije Universiteit Medical Center, Amsterdam, the Netherlands

E Bergers

MS Center, Vrije Universiteit Medical Center, Amsterdam, the Netherlands, Department of Radiology, Vrije Universiteit Medical Center, Amsterdam, the Netherlands

J Lindeboom

MS Center, Vrije Universiteit Medical Center, Amsterdam, the Netherlands, Department of Cognitive Neuropsychology, Vrije Universiteit Medical Center, Amsterdam, the Netherlands

M J Eikelenboom

MS Center, Vrije Universiteit Medical Center, Amsterdam, the Netherlands, Department of Neurology, Vrije Universiteit Medical Center, Amsterdam, the Netherlands

P H Scheltens

MS Center, Vrije Universiteit Medical Center, Amsterdam, the Netherlands, Department of Neurology, Vrije Universiteit Medical Center, Amsterdam, the Netherlands

F Barkhof

MS Center, Vrije Universiteit Medical Center, Amsterdam, the Netherlands, Department of Radiology, Vrije Universiteit Medical Center, Amsterdam, the Netherlands

C H Polman

MS Center, Vrije Universiteit Medical Center, Amsterdam, the Netherlands, Department of Neurology, Vrije Universiteit Medical Center, Amsterdam, the Netherlands

Multiple sclerosis (MS) is a multifocal demyelinating disease of the central nervous system, with lesions widespread through the brain and spinal cord. An important manifestation is cognitive impairment, which, though difficult to measure, may have a major social impact. To better understand the relationship between structural tissue damage and cognitive impairment, we examined the extent and spatial distribution of brain lesions, as measured by magnetic resonance imaging (MRI), in relation to abnormal cognitive performance as measured by the Brief Repeatable Battery (BRB) in 82 MS patients. Possible confounders, like fatigue, pain and depression were also assessed. Brain MR image analysis included hyperintense T2 and hypointense T1 lesion load in the whole brain and the four lobes separately, as well as whole brain volume measurements. Cognitive impairment (defined as more than two abnormal tests) was found in 67% of the patients. Moderately strong correlations were found between the subtests of the BRB and the lesion loads in the brain regions hypothesized to be associated with that cognitive test, although these correlations were in general not much stronger than those between the subtests and the overall lesion load (due to strong interrelationships). The Spatial Recall Test correlated best with parietal lesion load; the Symbol Digit Modalities Test, the Paced Auditory Serial Addition Task (PASAT) and the Word List Generation best with frontal, parietal and temporal lesion load; while the Verbal List Generation Test Index correlated only with atrophy. Atrophy and lesion load were the main factors determining the test scores, explaining 10-25% of the variance in the test results, and were more important than fatigue, pain and depression; only depression had a minor, but significant, additional effect on the PASAT. In conclusion, cognitive impairment in MS is moderately dependent on amount (and distribution) of structural brain damage, especially in the more physically impaired patients group.

Key Words: magnetic resonance • multiple sclerosis • neuropsychology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
X Lin, C R Tench, P S Morgan, and C S Constantinescu
Use of combined conventional and quantitative MRI to quantify pathology related to cognitive impairment in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, April 1, 2008; 79(4): 437 - 441.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
M. Summers, L. Fisniku, V. Anderson, D. Miller, L. Cipolotti, and M. Ron
Cognitive impairment in relapsing--remitting multiple sclerosis can be predicted by imaging performed several years earlier
Multiple Sclerosis, March 1, 2008; 14(2): 197 - 204.
[Abstract] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
P. Papathanasopoulos, L. Messinis, E. Lyros, A. Kastellakis, and G. Panagis
Multiple Sclerosis, Cannabinoids, and Cognition
J Neuropsychiatry Clin Neurosci, February 1, 2008; 20(1): 36 - 51.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
R H. Lazeron, L M. de Sonneville, P Scheltens, C H Polman, and F Barkhof
Cognitive slowing in multiple sclerosis is strongly associated with brain volume reduction
Multiple Sclerosis, November 1, 2006; 12(6): 760 - 768.
[Abstract] [PDF]